Filing Details
- Accession Number:
- 0001209191-23-053109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-10-18 17:39:48
- Reporting Period:
- 2023-10-16
- Accepted Time:
- 2023-10-18 17:39:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 731766 | Unitedhealth Group Inc | UNH | Hospital & Medical Service Plans (6324) | 411321939 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645325 | Erin Mcsweeney | C/O Unitedhealth Group 9900 Bren Road East Minnetonka MN 55343 | Evp Chief People Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-10-16 | 4,498 | $302.20 | 13,716 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-10-16 | 4,498 | $544.28 | 9,218 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Options (right to buy) | Disposition | 2023-10-16 | 4,498 | $0.00 | 4,498 | $302.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,750 | 2023-02-13 | 2030-02-13 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades ranging from approximately $544.200 to $544.545 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected.
Billionaire Hedge Funds
